Mortality Down for U.S. Patients Treated by International Doctors

Share this content:
Mortality Down for U.S. Patients Treated by International Doctors
Mortality Down for U.S. Patients Treated by International Doctors

MONDAY, Feb. 6, 2017 (HealthDay News) -- Mortality rates are lower for older Americans treated by doctors trained in other countries than by those who went to a U.S. medical school, according to research published online Feb. 3 in The BMJ.

The study, led by Yusuke Tsugawa, M.D., from the Harvard School of Public Health in Boston, included information from more than 1.2 million Medicare patients aged 65 and older. All had been admitted to the hospital between 2011 and 2014.

The researchers found that the 30-day mortality rate was 11.2 percent for patients treated by foreign-trained doctors and 11.6 percent for those treated by U.S.-trained doctors. There was no difference in hospital readmission rates. However, the cost of care was slightly higher for patients cared for by foreign-trained doctors ($1,145 versus $1,098).

"Our findings should reassure policymakers and the public that our current approach to licensing international medical graduates in the United States is sufficiently rigorous to ensure high-quality care," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »